+Health Care | 861 days ago

The Drug Industry Threatens To Oppose The Health Bill

By Karen Tumulty

The Associated Press reports that in the wake of President Obama’s decision to push for a shorter period of exclusivity for biologics, the drug lobby is threatening to walk away from its deal to support the bill:

+Health Care | 861 days ago

More on Obama and the Biotech Industry

By Karen Tumulty

It was a surprise indeed. Most people had figured that the biologic drug industry had sealed the deal for 12 years of protection from generic competition when it succeeded in getting language to that effect in both the House and Senate health care bills. Although President Obama had supported shorter protection of seven years,* there [...]

+Uncategorized | 861 days ago

Health Care: Is Obama Taking on the Biotech Industry?

By Karen Tumulty

A while back, Michael Scherer and I wrote this story about how the biotech industry has been one of the big winners in the health care debate. Maybe not so much, it now appears. The New York Times reports that President Obama may be making a last stand to bring lower-cost generic biologics to market [...]

+Health Care | 946 days ago

Health Reform: How The Drug Companies Won A Big One

By Karen Tumulty

$609,000 a day. That’s how much the drug and biotech companies have been spending to influence Congress in the health reform debate, more than any other industry. So it’s no surprise that they have been extraordinarily successful. In the upcoming issue of dead-tree TIME, Michael Scherer and I look behind the scenes at the fight [...]